Market Place
Sourcing Support
All News #Library
Biotech
Ractigen Secures NMPA IND for RAG-01 Phase II in NMIBC
19 Mar 2026 //
PR NEWSWIRE
Ractigen Announces 1st Patient Dosed in Ph 2 Trial of RAG-17
13 Jan 2026 //
PR NEWSWIRE
Ractigen Initiates First Patient Dosing In IIT Study Of RAG-18
12 Dec 2025 //
PR NEWSWIRE BIO
Ractigen`s RAG-17 ALS Data Impresses at AAN 2025: Wins Top Award
09 Apr 2025 //
PR NEWSWIRE
Ractigen Therapeutics Doses 1st Patient in Phase I Trial for RAG-17
24 Dec 2024 //
PR NEWSWIRE
Ractigen Announces Positive RAG-17 ALS-SOD1 Trial Data
10 Sep 2024 //
PR NEWSWIRE
Ractigen Gets FDA Fast Track For RAG-01 saRNA Therapy
21 May 2024 //
PR NEWSWIRE
Ractigen`s RAG-17 For SOD1-ALS Receives China IND Approval
15 May 2024 //
PR NEWSWIRE
Ractigen Advances into Clinical Stage with Groundbreaking saRNA Drug, RAG-01
06 Dec 2023 //
GLOBENEWSWIRE
Ractigen Presents Preclinical Results of Its saRNA Therapeutic Targeting DMD/BMD
02 Nov 2023 //
GLOBENEWSWIRE
Ractigen Announces Dosing of First Patient in First in Human Trial of RAG-17
05 Jun 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.